Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

Over the past few months, several op-eds and commentaries have offered solutions to keep U.S. science moving forward in the ...

Eric Green said the process leading to his ouster as a NIH institute director by the Trump administration remains "shrouded ...

State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening ...

Policymakers will need to address the true drivers of high drug prices here at home, while simultaneously pressing our allies ...

As federal grants to study the use of race in clinical algorithms dry up researchers are looking for other funding sources.

In the debate over Medicaid reform, one dubious claim keeps getting tossed around. But the evidence for it is weak.

Good morning. You’ve got barely two more days to nominate a promising young researcher for this year’s STAT Wunderkinds. Think postdocs, interns, fellows — they’re not in charge yet, but they will be ...

Republicans across the House and Senate are still working out significant disagreements on restrictions to provider taxes and ...

There seemed to be one question on the minds of many senators grilling Susan Monarez, President Trump’s pick to run the ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Viking Therapeutics announced the start of Phase 3 studies involving its injectable, GLP-1/GIP-targeted obesity drug, called ...